Letters Reframing relations with Pharma

Voluntarism is not enough

BMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b762 (Published 24 February 2009) Cite this as: BMJ 2009;338:b762
  1. John H Noble Jr, retired endowed professor for social justice, Catholic University of America, Washington, DC1
  1. 1Georgetown, TX 78633, USA
  1. jhnoble{at}verizon.net

    Krumholz and Ross’s six recommendations to regulate the pharmaceutical industry make sense but do not go far enough to assure compliance.1 They are much too dependent on the voluntarism of …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial